Role
- Deliver GLP and non-GLP i) Biomarker Testing, ii) Pharmacokinetic/Toxicokinetic Analysis, and iii) other Bioanalysis Methods such as Bioavailability, Bioequivalence, and ADA Immunogenicity Assay
- Independently develop customized, robust, and highly sensitive immunoassay using ELISA, MSD, Luminex, qPCR, or commercially available assay kits
- Perform fit-for-purpose Ligand Binding Assay (LBA) method validation, run high-quality, bioanalytical sample analysis, and prepare timely documentation and reports covering objectives, methods, and results
- Act as principal investigator, take responsibility for assigned projects, and supervise/train junior team members
- Troubleshoot assay, identify instrument issues (ELISA, MSD, Luminex, Western Blot, and qPCR), and resolve with vendors
- Follow Good Laboratory Practices (GLP), Company Standard Operating Procedures (SOPs), and Sponsor Study protocols
Qualifications
- Ph.D. (2+ years) / M.S. (4+ years) in biology, biochemistry, or related areas
- Hands-on experience with pharmacokinetic (PK) studies, toxicokinetics (TK) studies, biomarker testing, immunogenicity (ADA) testing, cell-based assay, cytotoxicity assay, and mechanism of action studies, as well as ELISA, MSD, Luminex, Western Blot, qPCR, and c orresponding software
- Familiarity with Thermofisher’s Watson LIMS and small molecule bioanalysis is a huge plus
Compensation and Benefits
- Competitive compensation commensurate with industry experience
- Discretionary performance bonus at year-end
- Two weeks paid annual vacation
- 401k match and healthcare coverage to eligible employees
- Accelerated career progression with flexibility to expand role and grow into the next level
Industry
- Biotechnology
- Pharmaceuticals
- Outsourcing/Offshoring
Employment Type
- Full Time
If interested, please e-mail your resume to careers@nebiolab.com.
NOTE: PLEASE SUBMIT BOTH RESUME AND COVER LETTER TO APPLY FOR THIS JOB. KINDLY DISCUSS YOUR MOTIVATION, RELEVANT EXPERIENCE, SALARY REQUIREMENTS, AND VISA STATUS IN YOUR SUBMISSION.